A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy

[1]  T. Ochiya,et al.  A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes , 2019, Nature Communications.

[2]  E. Miyaoka,et al.  Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010 , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  T. Ochiya,et al.  Circulating miRNA panels for specific and early detection in bladder cancer , 2018, Cancer science.

[4]  G. Rubin,et al.  Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility. , 2019, Journal of the American College of Radiology : JACR.

[5]  T. Ochiya,et al.  Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer , 2018, Clinical Cancer Research.

[6]  T. Ochiya,et al.  Integrated extracellular microRNA profiling for ovarian cancer screening , 2018, Nature Communications.

[7]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[8]  A. Seth,et al.  Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer , 2018, AntiCancer Research.

[9]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[10]  L. Tang,et al.  miR-17-3P regulates the proliferation and survival of colon cancer cells by targeting Par4. , 2017, Molecular medicine reports.

[11]  Ahmedin Jemal,et al.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.

[12]  Wenjie Zhu,et al.  MiR-1268b confers chemosensitivity in breast cancer by targeting ERBB2-mediated PI3K-AKT pathway , 2017, Oncotarget.

[13]  T. Gambichler,et al.  Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma. , 2017, Journal of dermatological science.

[14]  T. Ochiya,et al.  Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review , 2017, International Journal of Clinical Oncology.

[15]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  X. Kong,et al.  Long Noncoding RNA GCASPC, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase-Dependent Cell Proliferation in Gallbladder Cancer. , 2016, Cancer research.

[17]  T. Ochiya,et al.  Novel combination of serum microRNA for detecting breast cancer in the early stage , 2016, Cancer science.

[18]  E. Wickstrom,et al.  Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity , 2015, PloS one.

[19]  Qiong Zhang,et al.  Combined assays for serum carcinoembryonic antigen and microRNA-17-3p offer improved diagnostic potential for stage I/II colon cancer. , 2015, Molecular and clinical oncology.

[20]  Wei Zhao,et al.  Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer. , 2015, International journal of clinical and experimental medicine.

[21]  X. Chen,et al.  Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma , 2015, Scientific Reports.

[22]  Massimo Bellomi,et al.  miR-Test: a blood test for lung cancer early detection. , 2015, Journal of the National Cancer Institute.

[23]  Motohiro Kojima,et al.  MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers , 2015, PloS one.

[24]  Juan Zhao,et al.  Clinical use of microRNAs as potential non‐invasive biomarkers for detecting non‐small cell lung cancer: A meta‐analysis , 2015, Respirology.

[25]  Qian Zhang,et al.  Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer. , 2014, Oncology reports.

[26]  C. la Vecchia,et al.  Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[28]  Zuhong Lu,et al.  miRNA in Plasma Exosome is Stable under Different Storage Conditions , 2014, Molecules.

[29]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[30]  E. Lianidou,et al.  Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. , 2013, The Journal of molecular diagnostics : JMD.

[31]  Burton B. Yang,et al.  Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion , 2013, Nucleic acids research.

[32]  E. Scarpi,et al.  Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC , 2013, International journal of molecular sciences.

[33]  Wei-Yang Lu,et al.  Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways , 2013, Journal of Cell Science.

[34]  Paul Hofman,et al.  Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC , 2013, PloS one.

[35]  Burton B. Yang,et al.  Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 , 2012, Oncotarget.

[36]  S. Singhal,et al.  MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma , 2012, PloS one.

[37]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[38]  Ugo Pastorino,et al.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  X. Chen,et al.  Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis , 2011, International journal of cancer.

[40]  Feng Jiang,et al.  Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers , 2011, BMC Cancer.

[41]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[42]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[43]  Yi Zhu,et al.  Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non–small cell lung cancer , 2011, Chinese journal of cancer.

[44]  Feng Jiang,et al.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers , 2010, International journal of cancer.

[45]  F. Jiang,et al.  Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers , 2010, Modern Pathology.

[46]  Peter C Austin,et al.  Some Methods of Propensity‐Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations , 2009, Biometrical journal. Biometrische Zeitschrift.

[47]  H. Namba,et al.  Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells , 2008, Cancer science.

[48]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[49]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[50]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[51]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.